• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用分子数据对中枢神经系统肿瘤进行亚型分类的最新进展。

Recent advances in subtyping tumors of the central nervous system using molecular data.

机构信息

a Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen , Eberhard Karls University of Tuebingen , Tuebingen , Germany.

b Center for CNS Tumors, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen , Eberhard Karls University of Tuebingen , Tuebingen , Germany.

出版信息

Expert Rev Mol Diagn. 2017 Jan;17(1):83-94. doi: 10.1080/14737159.2017.1266259. Epub 2016 Dec 9.

DOI:10.1080/14737159.2017.1266259
PMID:27893285
Abstract

Primary brain tumors account for substantial morbidity and mortality. They often infiltrate the brain diffusely, continue growing, and cause adverse events, such as headaches, seizures, and neurological deficits. The classification of primary brain tumors, based for decades on histology, has been fundamentally changed by the World Health Organization in 2016 by incorporation of molecular data. Areas covered: Literature from glioblastomas, high- and low-grade astrocytic, oligodendroglial, glioneuronal and ependymal tumors from the last five years were reviewed. Results from comprehensive molecular profiling of neoplasms and impact of recent molecular subtyping on neuropathological diagnosis are presented. Expert commentary: The identification of frequent acquired mutations shows that adult and pediatric glioblastomas have divergent biology with differing prognoses. Astrocytoma and oligodendroglioma are more closely related than previously thought. Molecular profiling now enables the precise classification of most diffuse gliomas into three clinically and therapeutically different subtypes according to the presence or absence of IDH mutation and 1p/19q codeletion. New subgroups with different clinical outcomes and anatomic locations have emerged in ependymomas and pediatric embryonal tumors.

摘要

原发性脑肿瘤发病率和死亡率都很高。它们常广泛浸润脑实质,持续生长,并导致不良事件,如头痛、癫痫发作和神经功能缺损。几十年来,原发性脑肿瘤的分类一直基于组织学,2016 年世界卫生组织(WHO)通过纳入分子数据对其进行了根本性的改变。

涵盖领域

对过去五年间胶质母细胞瘤、高低级别星形细胞瘤、少突胶质细胞瘤、胶质神经元肿瘤和室管膜肿瘤的文献进行了回顾。本文还介绍了肿瘤综合分子分析的结果,以及最近的分子分型对神经病理诊断的影响。

专家评论

频繁获得的突变的鉴定表明,成人和儿童胶质母细胞瘤具有不同的生物学特性,其预后也不同。星形细胞瘤和少突胶质细胞瘤的关系比以前认为的更密切。分子分析现在可以根据 IDH 突变和 1p/19q 缺失情况,将大多数弥漫性神经胶质瘤精确地分为三种在临床和治疗上具有显著差异的亚型。在室管膜瘤和儿童胚胎性肿瘤中出现了具有不同临床结局和解剖位置的新亚组。

相似文献

1
Recent advances in subtyping tumors of the central nervous system using molecular data.利用分子数据对中枢神经系统肿瘤进行亚型分类的最新进展。
Expert Rev Mol Diagn. 2017 Jan;17(1):83-94. doi: 10.1080/14737159.2017.1266259. Epub 2016 Dec 9.
2
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.使用下一代测序技术对间变性少突胶质细胞瘤进行分子分类:欧洲癌症研究与治疗组织(EORTC)脑肿瘤组26951前瞻性随机III期试验报告
Neuro Oncol. 2016 Mar;18(3):388-400. doi: 10.1093/neuonc/nov182. Epub 2015 Sep 9.
3
Characterization of gliomas: from morphology to molecules.胶质瘤的特征:从形态学到分子层面
Virchows Arch. 2017 Aug;471(2):257-269. doi: 10.1007/s00428-017-2181-4. Epub 2017 Jul 4.
4
Further understanding of the pathology of glioma: implications for the clinic.对胶质瘤病理学的进一步理解:对临床的启示
Expert Rev Neurother. 2016 Sep;16(9):1055-65. doi: 10.1080/14737175.2016.1194755. Epub 2016 Jun 16.
5
WHO 2016 Classification of gliomas.世界卫生组织 2016 年版《脑肿瘤分类》。
Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150. doi: 10.1111/nan.12432.
6
Grade II and III Oligodendroglioma and Astrocytoma.二级和三级少突胶质细胞瘤和星形细胞瘤。
Neurol Clin. 2018 Aug;36(3):467-484. doi: 10.1016/j.ncl.2018.04.005. Epub 2018 Jun 15.
7
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
8
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.告别少突星形细胞瘤:原位分子遗传学支持将其归类为少突胶质细胞瘤或星形细胞瘤。
Acta Neuropathol. 2014 Oct;128(4):551-9. doi: 10.1007/s00401-014-1326-7. Epub 2014 Aug 21.
9
Biomarker-driven diagnosis of diffuse gliomas.基于生物标志物的弥漫性胶质瘤诊断。
Mol Aspects Med. 2015 Nov;45:87-96. doi: 10.1016/j.mam.2015.05.002. Epub 2015 May 21.
10
Neoplastic Myelopathies.肿瘤性脊髓病
Continuum (Minneap Minn). 2018 Apr;24(2, Spinal Cord Disorders):474-496. doi: 10.1212/CON.0000000000000585.

引用本文的文献

1
Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging.扩散峰度成像中的胶质瘤特异性扩散特征
J Clin Med. 2021 May 26;10(11):2325. doi: 10.3390/jcm10112325.
2
Tropism of mesenchymal stem cell toward CD133 stem cell of glioblastoma in vitro and promote tumor proliferation in vivo.间质干细胞对胶质母细胞瘤 CD133 干细胞的体外趋化性及其在体内促进肿瘤增殖。
Stem Cell Res Ther. 2018 Nov 9;9(1):310. doi: 10.1186/s13287-018-1049-0.
3
Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion.胶质瘤干细胞样细胞存活和侵袭的分子及微环境决定因素
Front Oncol. 2017 Jun 16;7:120. doi: 10.3389/fonc.2017.00120. eCollection 2017.